These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


587 related items for PubMed ID: 19077928

  • 21. Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate.
    Della Paschoa OE, Voskuyl RA, Danhof M.
    Br J Pharmacol; 1998 Dec; 125(7):1610-6. PubMed ID: 9884091
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedication.
    May TW, Rambeck B, Neb R, Jürgens U.
    Ther Drug Monit; 2007 Dec; 29(6):789-94. PubMed ID: 18043477
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock.
    Borowicz KK, Malek R, Luszczki JJ, Ratnaraj N, Patsalos PN, Czuczwar SJ.
    Epilepsy Behav; 2007 Aug; 11(1):6-12. PubMed ID: 17602881
    [Abstract] [Full Text] [Related]

  • 27. Interactions between zonisamide and conventional antiepileptic drugs in the mouse maximal electroshock test model.
    Borowicz KK, Luszczki JJ, Sobieszek G, Ratnaraj N, Patsalos PN, Czuczwar SJ.
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):265-72. PubMed ID: 16876388
    [Abstract] [Full Text] [Related]

  • 28. Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis.
    Bae EK, Lee J, Shin JW, Moon J, Lee KJ, Shin YW, Kim TJ, Shin D, Jang IJ, Lee SK.
    Seizure; 2016 Apr; 37():8-12. PubMed ID: 26908152
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M, Albani F, Riva R, Candela C, Mohamed S, Baruzzi A.
    Ther Drug Monit; 2013 Dec; 35(6):849-52. PubMed ID: 23942540
    [Abstract] [Full Text] [Related]

  • 34. Population estimation regarding the effects of cytochrome P450 2C19 and 3A5 polymorphisms on zonisamide clearance.
    Okada Y, Seo T, Ishitsu T, Wanibuchi A, Hashimoto N, Higa Y, Nakagawa K.
    Ther Drug Monit; 2008 Aug; 30(4):540-3. PubMed ID: 18641551
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Population estimation of the effects of cytochrome P450 2C9 and 2C19 polymorphisms on phenobarbital clearance in Japanese.
    Goto S, Seo T, Murata T, Nakada N, Ueda N, Ishitsu T, Nakagawa K.
    Ther Drug Monit; 2007 Feb; 29(1):118-21. PubMed ID: 17304159
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
    Yegnanarayan R, Mahesh SD, Sangle S.
    Chronobiol Int; 2006 Feb; 23(5):1035-46. PubMed ID: 17050216
    [Abstract] [Full Text] [Related]

  • 40. Phenytoin Michaelis-Menten pharmacokinetics in Saudi patients.
    el-Sayed YM, Islam SI.
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):173-8. PubMed ID: 2714918
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 30.